Sorin has purchased the cardiac surgery cannulae manufacturing activities from its supplier Bioengineering Laboratories (BEL) located in Cantù (Como), Italy. BEL develops, manufactures and distributes disposable medical devices for urology, urodynamics, heart surgery and haemodialysis. The transaction relates to BEL's manufacturing activities of cardiac surgery cannulae, which the company was producing on an exclusive basis for Sorin. These cannulae are an integral part of Sorin's cannulae offering and generated revenues of around EUR 4mn in 2013.
After the acquisitions of Estech's minimally invasive cannulae product line in 2011 and the CalMed product line in 2012, this acquisition represents a further step in Sorin's strategy of strengthening its global position in this market segment.